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High heterogeneity of malaria 
transmission and a large sub-patent and diverse 
reservoir of infection in Wusab As Safil district, 
Republic of Yemen
Jackie Cook1*, Lynn Grignard2, Samira Al‑Eryani3, Mustafa Al‑Selwei4, Abraham Mnzava5, Hafed Al‑Yarie4, 
Alison Rand2, Immo Kleinschmidt1 and Chris Drakeley2
Abstract 
Background: Yemen remains the country with the highest malaria transmission within the Arabian Peninsula and a 
source of imported cases to neighbouring countries.
Methods: This study collected samples from individuals resident in a valley in Western Yemen as a baseline to exam‑
ine infection prevalence for a future trial. As well as rapid diagnostic test (RDT) and microscopy, a filter paper blood 
spot was collected for molecular and serological analyses.
Results: Samples were collected from 2261 individuals from 12 clusters across a study area of approximately 100 km2. 
Plasmodium falciparum infection prevalence was 12.4, 11.1 and 19.6 % by RDT, microscopy and polymerase chain 
reaction (PCR), respectively. RDT and microscopy did not detect 45 % of infections present, suggesting many infec‑
tions were low‑density. Infection prevalence and seroprevalence were highly heterogeneous between clusters, with 
evidence of higher exposure in clusters close to the wadi. The mean multiplicity of infection (MOI) was 2.3 and high 
heterozygosity and allelic richness were detected.
Conclusions: This highly diverse parasite population suggests a high degree of transmissibility and coupled with the 
substantial proportion of low‑density infections, may pose challenges for malaria control and elimination efforts.
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Background
The Arabian Peninsula, comprising of Bahrain, Kuwait, 
Oman, Saudi Arabia, Yemen, Qatar and the United Arab 
Emirates, has made great strides towards malaria elimi-
nation over the past 50 years. Of the seven countries in 
the region, only Saudi Arabia and Yemen still experience 
ongoing local transmission [1]. Whilst transmission in 
Saudi Arabia is contained to two south western provinces 
[2], Yemen struggles with ongoing transmission across 
the country, with an estimated 25 % of the population at 
risk of transmission (>1 case per 1000 population) [3].
Yemen is one of the poorest and least developed coun-
tries in the Arabian Peninsula and the combination of 
political unrest and widespread resistance to chloro-
quine, which was the first-line anti-malarial drug until 
2005, resulted in a resurgence of malaria during the 
1990s, exacerbated by widespread flooding and unu-
sual rain patterns due to the El Niño climate oscillation 
[1]. In 2001, a new malaria strategic plan was imple-
mented by the government, which focused on the use 
of indoor residual spraying (IRS), larviciding and insec-
ticide-treated nets (ITN). In 2009, the first-line drug 
was switched to artemisinin-based combination therapy 
(ACT) [3]. Subsequently, malaria incidence appears to 
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have reduced, although data on confirmed cases are 
sparse [1].
Wadi Sukhmal is a valley in a mountainous area, 
located in Wusab As Safil district, approximately 
360 km from the capital Sana’a, in the west of the gover-
norate of Dhamar. The district is partially situated in the 
Tihama Plains which border the Red Sea in Yemen and 
Saudi Arabia. As an area with ongoing malaria trans-
mission this district was chosen as a site for a wider trial 
comparing the effects of combining long-lasting insec-
ticide-treated nets (LLIN) and IRS versus LLINs alone. 
A baseline malaria survey of the population was con-
ducted and filter paper samples collected from residents 
in order to estimate prevalence and genetic complexity 
of malaria infections. The genetic complexity and num-
ber of clones circulating in the parasite population in 
an area is often correlated with transmission intensity 
[4–7]. In addition, filter paper samples were tested for 
the presence of antibodies to Plasmodium falciparum 
and Plasmodium vivax antigens in order to estimate 
transmission intensity and reconstruct historical trans-
mission patterns in the area. Seroconversion rate and 
antibody dynamics in a population have been shown 
to correlate with transmission intensity in a number of 
settings and can be particularly useful in areas of low 
transmission [8–10]. All measures were collected as 
part of both the epidemiological characterization of the 
study area and as potential endpoints for the interven-
tion trial.
Methods
Setting
The study took place in Wusab As Safil district, situated 
in the Western foothills of Yemen with a population of 
approximately 150,000 (Fig. 1). Malaria across Yemen is 
unstable and related to altitude, rainfall and topography. 
In the study area, where altitude ranges between 601 
and 1000  m above sea level, malaria occurs 10  months 
of the year, although peaks in transmission are seen dur-
ing and following the rains and is predominantly due to 
P. falciparum. The main vectors are Anopheles arabien-
sis and Anopheles sergenti which are thought to breed in 
the fresh-water wadi (riverbed/stream) in the valley. The 
majority of the district is agricultural and is made up of 
mountains and valleys. The size of the study area was 
approximately 100 km2.
Fig. 1 Location of study district, South West Yemen
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Survey and sample collection
Samples were collected as part of a baseline survey for a 
larger trial to assess the effects of combining LLIN and IRS 
compared with LLIN alone. Clusters were selected from 
villages near Wadi Sukhmal, which was chosen due to 
high malaria incidence recorded by local health facilities. 
The survey took place in 12 clusters in the wadi that were 
randomized after stratification by distance to the wadi and 
baseline prevalence of infection, which was measured by 
rapid diagnostic test (RDT) and microscopy in October 
2011. The average population in the study clusters was 
800 (range: 337–1677). Clusters were separated by at least 
500 m. Filter paper samples were collected during a second 
baseline survey which took place in March 2012, prior to 
the trial intervention. Households were randomly sampled 
from within each cluster. Every child aged 15 and under 
who was present at the time of  visit had a finger prick 
blood sample taken for subsequent microscopy, as well as 
for an RDT (Carestart HRP-2, a P. falciparum specific test), 
and a filter paper for molecular and serological analyses.
Laboratory methods
DNA extraction and PCR amplification
DNA was extracted from three punches of 3 mm diameter 
from each filter paper sample (corresponding to approxi-
mately 10 µl of blood) using the Chelex method, as doc-
umented previously [8]. The extracted DNA (5  µl) was 
amplified by 18S ribosomal DNA (rDNA) nested PCR 
[9] using primers listed in Table  1. Subsequently species 
specific (P. falciparum, Plasmodium malariae, P. vivax) 
nested PCR was performed (Table  1). P. malariae and 
P. vivax PCR were only run on samples from three selected 
clusters due to suspected low prevalence of these species. 
Nested PCR products were analysed on 1.5 % agarose gels.
MSP‑2 genotyping
The msp2 genotyping was adapted from a published 
protocol [10]. Briefly, 5 µl of Chelex-extracted DNA was 
added to the primary PCR containing 500  nM forward 
and reverse primers (Table 1). The nested PCR contained 
300 nM forward primer S1Tail and 300 nM fluorescently 
labelled reverse primers M5 (Fc27 family specific) and N5 
(3D7 allelic family specific).
Samples were analysed together with 500-ROX size 
standard (Applied Biosystems) at the MRC Genomics 
Core Facility (Imperial College, Hammersmith Campus). 
The data was analysed using the GeneMapper Software 
(Applied Biosystems). All detected peaks were sorted by 
size and divided into three base pair bins to call the alleles.
Enzyme‑linked immunosorbent asssay (ELISA)
Filter paper samples were stored at 4  °C with desiccant 
until processed, as previously described [11]. Samples 
were tested at a final serum dilution equivalent of 1:1000 
for human immunoglobulin G antibodies against P. falci-
parum and P. vivax merozoite surface protein 119  (MSP-
119) and P. vivax apical membrane antigen-1 (AMA-1) and 
1:2000 for antibodies against P. falciparum AMA-1 using 
ELISA methods described in detail previously [11]. Opti-
cal Densities (OD) were normalized against the standard 
curve on each plate to account for differences between 
ELISA batches. ELISA results for each antigen were clas-
sified as positive and negative using a mixture model, as 
previously described [11]. Individuals were classed as pos-
itive if they had antibodies to either antigen.
Data analyses
Statistical analysis was performed using STATA 13 
(StataCorp, Texas, US). RDT and microscopy results were 
compared using Cohen’s kappa. Sensitivity and specificity 
of RDT and microscopy results were calculated using P. 
falciparum PCR as the gold standard. Standard errors of 
all prevalence estimates were adjusted using robust vari-
ance estimates [12] as implemented in the svy commands 
in Stata [13] to account for between cluster variation of 
responses, using household or cluster as primary sam-
pling unit when presenting cluster-level or overall preva-
lence, respectively. To examine the effect of age on MOI 
and prevalence, age data was split into 0–1  year olds, 
1–5  year olds and 5–15  year olds. The non-parametric 
Spearman’s Rho test was used to measure associations at 
an individual and cluster level.
Genetic diversity and population structure
The multiplicity of infection was defined as the number 
of different msp-2 alleles detected in one sample. The 
Table 1 Primers and sequences used for nested PCR
Snounou PCR
Primary rPLU6 5′TTAAAATTGTTGCAGTTAAAACG3′
rPLU5new 5′CYTGTTGTTGCCTTAAACTTC3′
P. falciparum rFAL1 5′TTAAACTGGTTTGGGAAAACCAAATATATT3′
rFAL2 5′ACACAATAGACTCAATCATGACTACCCGTC3′
P. malariae rMAL1 5′ATAACATAGTTGTACGTTAAGAATAACCGC3′
rMAL2 5′AAAATTCCCATGCATAAAAAATTATACAAA3′
P. vivax rVIV1 5′CGCTTCTAGCTTAATCCACATAA3′
rVIV2 5′ACTTCCAAGCCGAAGCAAAGAAA 3′
MSP2 PCR
 Primary S2‑Fw 5′GAA GGT AAT TAA AAC ATT GTC3′
S3‑REv 5′GAG GGA TGT TGC TGC TCC ACA G3′
 Nested S1Tail 5′GCT TAT AAT ATG AGT ATA AGG AGA A3′
M5 5′‑6FAM‑GCA TTG CCA GAA CTT GAA3′
N5 5′‑VIC‑CTG AAG AGG TAC TGG TAG A3′
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expected heterozygosity index (He), which measures the 
diversity at a locus, was calculated using the Excel Micro-
satellite Toolkit software [14]. Heterozygosity can range 
from 0 to 1, where low heterozygosity indicates inbreed-
ing, or a small population diversity, whilst a high het-
erozygosity indicates the presence of genetic variability. 
Allelic richness, which is the mean number of alleles per 
locus normalized to allow for sample size among popula-
tions, was calculated using FSTAT software. In addition, 
the fixation index (Wright’s F statistic), a measure of pop-
ulation variance, was calculated using FSTAT allowing 
55,000 permutations.
Serological analyses
Seroprevalence to P. falciparum and P. vivax antigens was 
modelled against age using a simple reversible catalytic 
model as previously described [15]. In order to examine 
whether a change in transmission intensity had occurred, 
profile likelihood plots were generated to see whether fit-
ting a model with two seroconversion rates may be more 
appropriate than a model with a single seroconversion 
rate [16]. A likelihood ratio test was used to determine 
which model fitted the data best.
Ethics approval
Ethics approval was obtained from the National Com-
mittee for Health Research, Ministry of Health, Yemen. 
Informed consent was obtained from all participants or 
their guardians, prior to the collection of samples.
Results
Study population
A total of 2261 filter paper samples were collected, with 
an average of 185 children per cluster (range 163–216) 
aged <16  years. The median age was 6  years (25–75 
range: 3–9) and 53  % were female. 1341 (60  % of study 
population) individuals were classified as living within 
500 m of the wadi.
Plasmodium infections detected by RDT and microscopy
Plasmodium falciparum prevalence was 12.4  % (10.3–
14.6) (n = 281) and 11.1 % (9.2–13.1) (n = 237) by RDT 
and microscopy, respectively, with a Cohen’s kappa of 
0.83. Of the 281 RDT positive individuals, 62 were not 
positive by microscopy, whilst of 237 microscopy P. falci-
parum positive individuals, 16 were not positive by RDT. 
In addition, microscopy identified 19 P. malariae infec-
tions (overall prevalence of 0.8 %).
Plasmodium infections detected by PCR
PCR results were successfully obtained for 2181 samples. 
Of these, 19.6 % (95 % CI 17.3–21.9) (n = 430) were posi-
tive for P. falciparum. Further analysis for malaria species 
was performed in three clusters (clusters 5, 10 and 12) in 
which four P. vivax infections were found [all in cluster 
12, (2.2 %)] and 17 P. malariae infections were found [in 
clusters 5 (2 %), 10 (6 %) and 12 (0.6 %)].
Prevalence of low‑density malaria infections and spatial 
heterogeneity
Using P. falciparum PCR as the gold standard, RDT had 
a sensitivity of 45.8  % (41.0–50.6) and a specificity of 
95.4  % (94.3–96.3) and P. falciparum microscopy had 
a sensitivity of 41.6  % (36.9–46.4) and a specificity of 
97.1 % (96.3–97.9), although sensitivity for both diagnos-
tic methods varied substantially by cluster, ranging from 
0 % in cluster 1 to 78.3 % in cluster 4. In general, sensi-
tivity was higher in clusters of higher prevalence, sug-
gesting more of the infections were high density in these 
areas (Fig. 2). Approximately 45 % of P. falciparum infec-
tions present were not detected by RDT and microscopy. 
This did not vary by age group. Only 5 of 11 microscopy 
positive P. malariae infections that were tested with PCR 
were confirmed as positive.
As with the other parasite prevalence measures, para-
site prevalence by PCR ranged substantially by clus-
ter (Figs.  2, 3). The highest prevalence was detected in 
Cluster 4 (46.0 %, 92/200) with cluster 2 also being high 
(37.6  %, 78/206). The lowest prevalence was in clusters 
1 and 9, where prevalence was 2.2  % (4/185 and 4/182 
respectively) (Table  2). Parasite prevalence by PCR was 
highest in clusters that were located on the wadi (26.8 %, 
355/1325), compared with clusters located >500 m from 
the wadi (8.5  %, 72/850 p  <  0.001). This difference was 
even more pronounced with RDT or microscopy parasite 
measures (19.9 and 1.6 % for RDT and 16.8 and 1.3 % for 
microscopy) (Fig. 4).  
Seroprevalence to P. falciparum antigens
Seroprevalence for P. falciparum antigens was 23.1  % 
(n  =  453), 21.2  % (n  =  471) and 31.8  % (n  =  729) for 
MSP-119, AMA-1, or either antigen, respectively. As 
with the parasitological results, seroprevalence ranged 
substantially between clusters, with clusters 2 and 5 hav-
ing the highest prevalence (58.5 %, 121/216 and 56.4 %, 
110/195 for either antigen, respectively) whilst clusters 1 
and 11 were low (9.2 %, 17/185 and 3.5 %, 6/178 for either 
antigen, respectively) (Table 2).
Seroprevalence to P. vivax antigens
Whilst P. vivax specific PCR was only performed on sam-
ples from three clusters, all samples were tested on P. 
vivax MSP-119 and AMA-1 antigens to look for P. vivax 
specific antibodies. Seroprevalence was 1.4  % (n =  30), 
2.2  % (n =  47) and 3.2  % (n =  75) for MSP-119, AMA-
1, or either antigen respectively. None of the four P. 
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vivax infections detected by PCR were antibody positive 
to either antigen. No children under 1  year of age were 
seropositive for any P. vivax antigens, with highest sero-
prevalence detected in 12–15 year olds (5.7 %). As with 
the other prevalence measures, seroprevalence to P. vivax 
antigens was highest in the clusters located closest to the 
wadi (4.5 %, 60/1341), compared to those located further 
away (1.7  %, 15/880). Sixty-five percent (n  =  49) of P. 
vivax serological positive samples were also positive for P. 
falciparum antibodies.
Historical patterns of transmission patterns elucidated 
from serological data
Age seroprevalence curves for responses to either P. fal-
ciparum antigen were modelled using a simple revers-
ible catalytic model for clusters within 500 m of the wadi 
and for those further away. The seroconversion rate in 
the clusters on the wadi was double that of the ones fur-
ther away (λ 0.22 and λ 0.11 respectively, equivalent to 
EIRs of approximately 15 and 3 [15]). Profile likelihood 
analysis showed no evidence for a recent change in trans-
mission in the low transmission clusters. However, in 
clusters close to the wadi, a model with a change in force 
of infection 9 years previously fit the data best (p < 0.001) 
(Fig.  5). In these clusters, seroconversion rates for chil-
dren under the age of nine were half that of those over 
the age of nine (λ 0.33 and λ 0.74 in children under and 
over nine, respectively).
Genetic diversity of Plasmodium falciparum infections
msp2 markers were amplified from 339 (79  %) of the P. 
falciparum positive samples (N = 430). A total of 84 dif-
ferent msp2 alleles were successfully genotyped, rang-
ing in size from 205 to 609 base-pairs. Of these, 62  % 
(n = 52) and 38 % (n = 32) belonged to the 3D7 and Fc27 
families respectively (Fig. 6). The frequency of individual 
3D7 alleles was low: all had a frequency below 5 %. 63 % 
(n = 211) of infections were made up of 2 or more alleles 
(range 1–10). The mean MOI was 2.3, with the high-
est MOI detected in cluster 5 (3.1) (Table  3). The MOI 
decreased slightly with age group, although this was 
not significant. Nor was there a significant relationship 
between clusters close or far from the wadi or between 
clusters themselves; all clusters had a number of infec-
tions consisting of more than one allele. The estimated 
heterozygosity was above 0.9 in all clusters apart from 
cluster 11 (0.75) (Table 3). Allelic richness was 11.7 and 
ranged from 3.9 to 11.6 by cluster. The overall fixation 
index for the 12 clusters was 0.029, which is suggestive 
of little genetic differentiation and frequent gene flow 
between all clusters. 
Correlations between metrics of transmission
At a cluster level, the parasite prevalence measures were 
strongly associated with P. falciparum seroprevalence 
(ρ 0.94 p < 0.001, ρ 0.86 p < 0.001 and ρ 0.90 p < 0.001 
for RDT, microscopy and PCR, respectively). All P. fal-
ciparum prevalence and seroprevalence measures were 
strongly correlated with allelic richness (ρ 0.90 p < 0.001, 
ρ 0.85 p = 0.001, ρ 0.85 p = 0.001, ρ 0.96 p < 0.001 for 
RDT, microscopy, PCR and seroprevalence respectively) 
and expected heterozygosity (ρ 0.85, p  <  0.001, ρ 0.83 
p =  0.002, ρ 0.75 p =  0.008, ρ 0.91 p  <  0.001). As pre-
viously described, expected heterozygosity was strongly 
correlated with allelic richness (ρ 0.97 p < 0.001). Inter-
estingly, cluster MOI was not significantly associated 
with any other measures. Correlations are shown in 
Additional file 1.
Discussion
Malaria remains a significant public health problem 
in Yemen. This study demonstrates the wide range of 
Fig. 2 Proportion of patent (detectable by a RDT and b microscopy) and sub‑patent (detected by PCR) P. falciparum infections by cluster
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malaria infection prevalence and exposure in commu-
nities separated by short distances in a single valley in 
Western Yemen using a variety of metrics. Parasite prev-
alence was notably high in some clusters (up to 46  %), 
although heterogeneity was marked. A large proportion 
of sub-patent infections were detected, indicating that 
diagnosis using RDTs or microscopy would leave a sig-
nificant number of infections untreated. Moreover, the 
Fig. 3 Prevalence for a RDT b Microscopy c PCR and d seroprevalence by cluster
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Table 2 P. falciparum prevalence as measured by RDT, microscopy, PCR and antibodies to either P. falciparum MSP-1 or 
AMA-1, by cluster
Tested RDT Pf microscopy Pf PCR Pf serology
Cluster N +ve % 95 % CI +ve % 95 % CI +ve % 95 % CI +ve % 95 % CI
1 185 1 0.5 −0.5, 1.6 1 0.5 −0.5, 1.6 4 2.2 −1.5, 5.8 17 9.2 3.2, 15.2
2 216 77 35.6 24.7, 46.6 61 27.8 18.6, 37 78 37.6 27.4, 47.7 121 58.5 49.6, 67.5
3 187 9 4.8 1.6, 8 0 0 0, 0 15 8 3, 13 60 32.1 24.7, 39.5
4 200 88 44 37.1, 50.9 77 38.5 31.8, 45.2 92 46 38.8, 53.2 118 59 51.8, 66.2
5 195 48 24.6 15.6, 33.6 44 22.6 15.1, 30.1 53 27.2 20.4, 34 110 56.4 47.1, 65.8
6 163 1 0.6 −0.6, 1.8 0 0 0, 0 31 19.1 11.9, 26.3 22 13.6 7.2, 20
7 173 9 6 1.5, 10.5 7 4.7 1.1, 8.3 27 18 11, 25 32 17.3 6.4, 28.2
8 180 20 10.9 3.7, 18.1 22 10.3 3.7, 17 40 23 16.2, 29.7 74 42.5 35.1, 50
9 182 3 1.6 −0.1, 3.4 3 1.6 −0.1, 3.4 4 2.2 0.3, 4.1 9 4.9 1.4, 8.5
10 184 15 8.2 3.2, 13.1 13 7.1 3.1, 11 44 23.9 17.5, 30.3 80 43.5 34.5, 52.5
11 178 0 0 0, 0 0 0 0, 0 6 3.5 1.2, 5.8 6 3.5 0.4, 6.7
12 179 10 5.6 1.7, 9.4 8 4.5 0.6, 8.3 33 18.4 11.9, 25 76 42.5 32.9, 52
Total 2220 281 12.7 10.5, 14.8 236 10.5 8.7, 12.3 427 19.6 17.3, 21.9 725 33.0 30.0, 36.0
Fig. 4 Proportion of patent (detectable by a RDT and b microscopy) and sub‑patent (detected by PCR) P. falciparum infections by distance to the 
wadi
Fig. 5 Seroprevalence curves to either P. falciparum antigen for a people living within 500 m of the wadi and b further than 500 m from the wadi. 
Black circles represent actual data, plotted at median percentiles for age and black line represents the results from a reversible catalytic model. In the 
clusters close to the wadi, there was evidence for a change in transmission 9 years prior to the survey—this dataset has been fitted allowing for two 
lambdas
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highly diverse nature of the parasite population in this 
study area is suggestive of a high degree of transmissibil-
ity and may pose a barrier for malaria control efforts in 
the region.
The marked heterogeneity of infection prevalence in 
this setting is surprising given the short distance between 
the clusters sampled i.e. prevalence between cluster 1 
(2 %) and 4 (46 %) despite only being 2 km apart (Fig. 3). 
Heterogeneity in infection has been reported in many 
settings [17, 18] although rarely to the same extreme as 
seen in this setting over such short distances [19, 20]. 
Variation in infection prevalence can be due to vari-
ability in risk factors such as use of interventions, poor 
quality housing or location relative to mosquito breeding 
sites. A clear risk factor in this setting was the wadi, with 
clusters located within 500 m of the wadi demonstrating 
consistently higher prevalence. The riverine environment 
is likely to be a breeding site for the primary malaria vec-
tor in the area, An. arabiensis [21] and one explanation 
for the high hetereogenity is that the range of the mos-
quitoes is relatively restricted and that there is limited 
mosquito movement between clusters. A recent study 
conducted in different districts in Yemen also found 
a range of parasite prevalences, although over a wider 
distance than is reported here [22]. In that study, house 
structure and occupation were most likely to influence 
prevalence. This information was not collected in the 
current study and is a limitation in maximizing the find-
ings from the data collected.
The high proportion of sub-patent infections poses 
challenges for malaria control and elimination efforts. 
This study observed discordance between microscopy 
Fig. 6 Frequency of a 3D7 and b Fc27 allelles in P. falciparum samples, Yemen
Table 3 Multiplicity of infection (MOI), allelic richness and heterozygosity at the msp2 alleles in P. falciparum infections 
in Yemen
Cluster No. of PCR positives MOI (range) Allelic richness Heterozygosity (He) Number of alleles sampled
1 4 1.75 (1–3) 5 0.905 5
2 57 1.67 (1–6) 10 0.94 34
3 9 2.22 (1–4) 8.5 0.937 12
4 76 2.43 (1–7) 11.7 0.973 51
5 50 3.06 (1–8) 11.3 0.969 41
6 17 2.71 (1–7) 7.8 0.878 17
7 14 1.64 (1–5) 9.1 0.94 15
8 34 2.65 (1–10) 9.9 0.941 34
9 1 2.00 (2)
10 40 1.88 (1–4) 11 0.967 35
11 5 1.40 (1–2) 3.9 0.75 4
12 29 2.28 (1–8) 10.5 0.954 28
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(which is the main diagnostic in Yemen) and RDT, as 
well as approximately 45 % of infections being missed by 
these methods. Whilst low parasite density infections are 
likely to be less infectious to mosquitoes [23], they still 
represent a risk for onward transmission and such a large 
reservoir is likely to play a role in transmission [24]. The 
proportion of sub-patent infections was higher further 
from the wadi, in the lower transmission clusters; 82 % of 
infections were sub-patent in the clusters further from the 
wadi, compared to 38 % in those close to the wadi. This is 
consistent with observations from large-scale comparison 
of PCR and RDT/microscopy which found the highest 
levels of sub-patent infections in low transmission set-
tings [24]. As molecular diagnostics have become more 
sensitive, it has become clear that low-density infections 
are often present in high numbers, even in areas of rela-
tively low transmission intensity [23, 25, 26]. The duration 
of these low-density infections, which are often asympto-
matic, has been shown to be much longer than thought 
[27], although data is relatively sparse. Chronic, low-
density infections are a barrier for malaria elimination in 
areas where Anopheles mosquitoes are still present.
The high diversity of the parasite population in this 
region was surprising although is consistent with other 
studies from Yemen [28, 29]. Previous molecular stud-
ies have noted that a highly diverse parasite population 
tends to be associated with higher malaria transmission 
[30]. In this study area, where there is a range of trans-
mission intensity, the genetic diversity was high, even 
in lower transmission clusters. This apparent discord-
ance may occur in areas where transmission has only 
recently reduced, such that there is only a subtle change 
in diversity [31] or when a change has not yet  become 
detectable [32, 33]. However, the serological results sug-
gest that transmission has been consistently low in the 
clusters further from the wadi, with no evidence for a 
recent change in transmission. High heterozygosity was 
also detected in nearby areas in a previous study [29] 
and is suggestive of a large parasite population circulat-
ing in Yemen. This could be influenced by population 
movement in the region, with the high level of parasite 
diversity in this study being similar to that seen in highly 
endemic African populations [10, 34].
In this study, there was no association found between 
MOI and transmission intensity. Whilst many studies 
have shown that MOI is higher in areas of greater trans-
mission intensity [10, 20], there have been other studies 
that demonstrate no correlation [35]. It is possible that 
the timing of the survey may have influenced this with a 
study in Senegal showing that MOI increased during the 
transmission season [36].
Serological data indicates a significant difference in 
exposure to infection between children born 9  years 
previously compared with those born more recently, with 
older children experiencing approximately double the 
transmission rate. This effect is most apparent in the clus-
ters located within 500 m of the wadi. This difference may 
be due to an age related behavioural pattern, for example 
if children over ten spend more time outdoors and/or in 
high-risk areas, as has been seen observed in South East 
Asia [37, 38] and South America [39, 40].
Alternatively, this difference could be indicative of a 
fall in transmission 9  years previously and in this case 
enhanced efforts of the malaria control programme, ini-
tiated in 2002. However, the fact that samples were only 
collected from those <16  years means it is difficult to 
fully reconstruct historical transmission patterns using 
serological data and it is possible a different pattern 
would have been apparent if samples from all ages had 
been examined.
Despite fewer samples being tested for P. vivax and P. 
malariae parasites using PCR, data suggest that P. vivax 
prevalence is extremely low with no infections detected 
by microscopy, in line with the national control pro-
gramme estimates [3]. Seroprevalence to P. vivax anti-
gens was below 10  % in all clusters, with only a small 
number of children with high antibody responses to 
either P. vivax antigen. Several P. malariae infections 
were identified in the clusters that were tested. This 
had also been detected in previous molecular studies 
in Yemen [41]. The presence of multiple Plasmodium 
species has implications for diagnosis, with RDT and 
microscopy lacking sensitivity for species other than P. 
falciparum.
As well as being informative for transmission intensity 
levels, understanding the genetic diversity of parasites in 
Yemen may help elimination programmes in the region to 
accurately classify a case as imported or locally acquired. 
Such a diverse parasite population may pose challenges 
for the effectiveness of malaria vaccines, which need 
to target the most common allelic families present in a 
region [42]. As has been seen in other settings [20, 28], 
3D7 alleles were more prevalent in this setting than the 
Fc27 family.
Conclusions
This study used a variety of metrics to identify extreme 
and relatively focal heterogeneity of malaria infection 
prevalence over small distances in the foothills of Yemen, 
including a high proportion of sub-patent infections. The 
parasite population was highly diverse, even in clusters 
of low prevalence, with transmission focused close to the 
wadi. Identifying risk factors for high prevalence, such as 
proximity to mosquito breeding sites or high proportions 
of the population travelling to high transmission areas, 
will enable intervention campaigns to target villages 
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appropriately and may result in a more cost-effective 
approach to reduce transmission in Yemen.
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